Dear Colleagues,

I, along with my co-directors, have the pleasure of inviting you to Save the Date for the 9th edition of the Kidney Disease Clinical Trialists Workshop, which will take place in the Embassy of France in Washington DC on April 4-5, 2025.

The Kidney Disease Clinical Trialists (KDCT) Workshop is a high level think-tank, with an exceptional expert faculty. It involves a limited number of attendees (up to 130) and includes distinguished nephrologists, clinical trialists, principal investigators and statisticians from academia, R&D pharma and device companies, NIH, EMA, PMDA and FDA experts.

The KDCT Workshop aims to foster an international exchange of ideas where we will brainstorm on trial design, conduct, ethics, interpretation, approvability and implementation encompassing drugs, devices, biomarkers and therapeutic strategies for kidney disease.

Our objectives are to produce relevant data from controlled kidney disease clinical trials (beyond cardiovascular outcomes trials) that will contribute to better clinical care and to understand the problems associated with making decisions about what constitutes relevant information, how to improve kidney disease clinical trials, and, as is commonly the case, how to satisfy regulatory authorities and payers.

We will get in touch with you soon with a formal invitation to join us at the KDCT 2025.

Professor Patrick Rossignol
Workshop Director

Workshop Co-Directors